TY - JOUR
T1 - Markers of ventricular repolarization and overall mortality in sleep disordered breathing
AU - Patel, Salma I.
AU - Zareba, Wojciech
AU - LaFleur, Bonnie
AU - Couderc, Jean Phillipe
AU - Xia, Xiaojuan
AU - Woosley, Raymond
AU - Patel, Imran Y.
AU - Combs, Daniel
AU - Mashaqi, Saif
AU - Parthasarathy, Sairam
N1 - Publisher Copyright: © 2022 Elsevier B.V.
PY - 2022/7
Y1 - 2022/7
N2 - Introduction: Variability and prolongation of ventricular repolarization – measured by changes in QT interval and QT variability are independently associated with ventricular arrhythmias, sudden death, and mortality but such studies did not examine the role of sleep-disordered breathing. We aimed to determine whether sleep-disordered breathing moderated the association between measures of ventricular repolarization and overall mortality. Methods: Eight hundred participants were randomly selected from each of the following four groups in the Sleep Heart Health Study: mild, moderate, severe or no sleep disordered breathing (n = 200 each). Overnight electrocardiograms were analyzed for QTc duration and QT variability (standard deviation of QT intervals, normalized QT interval variance and the short-term interval beat-to-beat QT variability). Cox proportional hazards penalized regression modeling was used to identify predictors of mortality. Results: Eight hundred of 5600 participants were randomly selected. The participants (68 ± 10 years; 56.8% male) were followed for an average of 8.2 years during which time 222 (28.4%) died. QTc, SDQT, and QTVN were associated with the presence of SDB (p = 0.002, p = 0.014, and p = 0.024, respectively). After adjusting for covariates, the presence of sleep-disordered breathing did not moderate the association between QTc length, QT variability and mortality (p > 0.05). Conclusion: Sleep-disordered breathing was associated with some measures of ventricular repolarization. However, sleep-disordered breathing was not an effect modifier for the relationship between QTc and QT variability and mortality.
AB - Introduction: Variability and prolongation of ventricular repolarization – measured by changes in QT interval and QT variability are independently associated with ventricular arrhythmias, sudden death, and mortality but such studies did not examine the role of sleep-disordered breathing. We aimed to determine whether sleep-disordered breathing moderated the association between measures of ventricular repolarization and overall mortality. Methods: Eight hundred participants were randomly selected from each of the following four groups in the Sleep Heart Health Study: mild, moderate, severe or no sleep disordered breathing (n = 200 each). Overnight electrocardiograms were analyzed for QTc duration and QT variability (standard deviation of QT intervals, normalized QT interval variance and the short-term interval beat-to-beat QT variability). Cox proportional hazards penalized regression modeling was used to identify predictors of mortality. Results: Eight hundred of 5600 participants were randomly selected. The participants (68 ± 10 years; 56.8% male) were followed for an average of 8.2 years during which time 222 (28.4%) died. QTc, SDQT, and QTVN were associated with the presence of SDB (p = 0.002, p = 0.014, and p = 0.024, respectively). After adjusting for covariates, the presence of sleep-disordered breathing did not moderate the association between QTc length, QT variability and mortality (p > 0.05). Conclusion: Sleep-disordered breathing was associated with some measures of ventricular repolarization. However, sleep-disordered breathing was not an effect modifier for the relationship between QTc and QT variability and mortality.
KW - Mortality
KW - QT interval
KW - QT variability
KW - Sleep apnea
KW - Sleep disordered breathing
KW - Ventricular repolarization
UR - http://www.scopus.com/inward/record.url?scp=85129704023&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85129704023&partnerID=8YFLogxK
U2 - 10.1016/j.sleep.2022.04.016
DO - 10.1016/j.sleep.2022.04.016
M3 - Article
C2 - 35533628
SN - 1389-9457
VL - 95
SP - 9
EP - 15
JO - Sleep Medicine
JF - Sleep Medicine
ER -